Login
← Go Back
Piramal Pharma
PPLPHARMA · Pharma > Pharmaceuticals & Drugs Listing date: Oct. 19, 2022
Stock Price vs Company Growth
1d
0.1%
1w
7.7%
1m
12.0%
3m
1.7%
6m
6.2%
1y
45.0%
all
5.4%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 216 0.1%
190
228
Company Overview
Sales
9,151 Cr
Growth: 12.7%
Profit after Tax
91.1 Cr
Growth: 134.3%
Mid Cap
28,738 Cr
P/E: 313.9x
Industry P/E: 33.3x
Fundamentals
Sales (Cr) ₹ 9,151
Growth 12.7%
EBITDA 15.8%
P/S 3.1x
Dividend 0.1%
P/E 313.9x
Book Value ₹ 61.1
PEG Ratio 24.8x
ROE 1.2%
P/B 3.5x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across many global facilities and a global distribution network in hundreds of countries. It includes PPS, PCC and the India Consumer Healthcare business, selling over-the-counter products.
Belongs to (25 Indices) view more
Investors (5)
vskr63
chethan3
ravi_kum...
Followers (2)
saurabh8...
varsha96